Risks in invasive procedures

Simple item page
dc.contributor.authorRaúl Martínez-Castro
dc.contributor.authorGilberto Barranco-Lampón
dc.contributor.authorLuara L. Arana-Luna
dc.contributor.authorJosé L. Álvarez-Vera
dc.contributor.authorFlavio Rojas-Castillejos
dc.contributor.authorRosalinda Peñaloza-Ramírez
dc.contributor.authorAdrián A. Carballo‐Zarate
dc.contributor.authorIrma Olarte-Carrillo
dc.contributor.authorJaime Israel-García Minamy
dc.contributor.authorJavier López‐Salazar
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:05:14Z
dc.date.available2026-03-22T19:05:14Z
dc.date.issued2023
dc.description.abstractPatients with myeloproliferative neoplasms have an increased risk of thrombosis and bleeding. This risk must be identified, as well as individualizing the therapeutic strategy before invasive procedures; adequate cytoreduction reduces the risk of complications.
dc.identifier.doi10.24875/gmm.m22000808
dc.identifier.urihttps://doi.org/10.24875/gmm.m22000808
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/73972
dc.language.isoes
dc.publisherAcademia Nacional de Medicina de México
dc.relation.ispartofGaceta Médica de México
dc.sourceCentro Medico Nacional Siglo XXI
dc.subjectMedicine
dc.subjectThrombosis
dc.subjectIntensive care medicine
dc.subjectRisk assessment
dc.subjectSurgery
dc.titleRisks in invasive procedures
dc.typearticle

Files

Collections

Artículo Científico Publicado